Main > NEPHROLOGY > Dialysis. Peritoneal > IcoDextrin Solution. > Production.

Product USA. B

CLASSIFICATION Market
OBSERVATION'S Product offers the potential for increased removal of fluid from the bloodstream during dialysis over currently available 1.5 percent and 2.5 percent dextrose solutions during "long dwell" dialysis exchanges. "Dwell" is the amount of time dialysis solution remains in the abdominal cavity during PD therapy. "Exchange" refers to the process of discarding used dialysis solution and instilling fresh solution into the abdominal cavity. Fluid removal is a cornerstone of dialysis therapy, since the patient's native kidneys have limited, if any, residual ability to eliminate excess fluid from the bloodstream
STATUS approved by the U.S. Food and Drug Administration (FDA) in December 2002 for sale in the United States. awaiting approval in Japan, is currently approved in 34 countries
UPDATE 20.03.2003
USES 9,000 end-stage renal disease (ESRD) patients using the solution worldwide
COMPANY This data is not available for free
TRADEMARK This data is not available for free

Want more information ?
Interested in the hidden information ?
Click here and do your request.


back